EKNL – Mega successful conference leading towards MAJOR contracts
EKNL’ s first major medical conference is now in the books and we anticipate MAJOR contracts to be unleashed this week that will no doubt be monsters.
EKNL met with key groups at the 13th annual Medical Conference in London, ON this weekend and the event has been xtremely successful. EKNL’s FDA approved FREMS technology to treat Neuopathy, was definitely a show stopper.
Dr. Ziemer, Director and Dr. Snow of 
Neurometrix, a NASDAQ Listed company (NURO) provided an exclusive hands on demonstration of their testing unit NC-Stat DPN devices which are now in over 100 Walmart stores . We expect these units to be in many more Walmart stores and even other retail outlets. The referrals for FREMS patients from these test devices will be HUGE and add significant $$ to EKNL’s bottom line.
We are on HIGH news watch for Major Contracts this week as indicated by EKNL
NCI will be providing demonstrations to a number of parties who have expressed serious interest in FREMS and are attending to finalize purchasing arrangements.
EKO International Corp – NeroVasc Clinical Inc. Presentation at the Canadian Federation of Podiatric Medicine Conference, London, Ontario PR Newswire (Wed 11:06AM EDT)
EKNL is primed for a MAJOR breakout run and we got an early indication on Friday with EKNL reaching a new all time high price of $0.775 . With major contracts on the way, share buy back, and uplisting to higher board like NASDAQ – our near term target on EKNL of $2 per share is close at hand and investors scooping super valued shares here stand to make MONSTER gains!
EKNL’s Technical indicators are showing ‘super bullish’ with barchart.com showing a “Strong” Buy opinion and no doubt we will be breaking record after record this week when the sales contracts start flying out of the company.
EKNL recent market shattering updates give HUGE valuation and potential to the company…
…BUT, IT IS WHAT’S STILL TO BE UNLEASHED BY EKNL THAT WILL NOT ONLY BE MIND ‘BLOWING’ IT WILL PROPEL EKNL PRICES ’SKY HIGH’ AND INTO RECORD TERRITORY
With an active float of only 5.5 Million shares and insiders not selling a single share , share inventory continues to dry up super quick making EKNL prices to move fast and furious towards higher levels.
ABOUT EKO INTERNATIONAL
EKO International Corp. is a holding company focused on growth through acquisition. Each acquisition must have substantial growth potential and is expected to add assets and/or cash-flow to the consolidated financial statements of the Company. The Company is willing to examine a variety of proposed target businesses and if interested, will negotiate terms and conditions of purchase favorable to itself.
